Discovery and development of therapeutic TACE antibodies

Discovery and development of therapeutic TACE antibodies

Bibliographic Details
Main Author:	Tape, Christopher James
Published:	University of Cambridge 2011
Subjects:	616.99
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.609820

Similar Items

Humoral immune response to melanoma : discovery and evaluation of anti-melanoma antibodies
by: Gilbert, Amy
Published: (2013)

Discovery and optimisation of small-molecule ERK5 inhibitors as cancer therapeutics
by: Myers, Stephanie May
Published: (2013)

The action of therapeutic antibodies of varying geometry on lymphoma cells
by: Smith, Andrew Mark
Published: (1998)

Construction and characterisation of anti-tumour antibody-based proteins for use in diagnostics and therapeutics
by: Paton, Lois
Published: (2016)

Development of targeted therapeutics for the treatment of glioblastoma
by: Jain, Mohit Laxmilal
Published: (2017)

The manipulation of cellular immunity by monoclonal antibodies in cancer patients
by: Hollingworth, James
Published: (1994)

Modulating autophagy for the therapeutic benefit of cutaneous melanoma
by: McKee, Christopher Sean
Published: (2013)

Discovery and characterisation of small RNAs in bone cancer
by: Green, Darrell
Published: (2016)

Development of a targeted diagnostic and therapeutic delivery system for cholangiocarcinoma
by: Nair, Amit
Published: (2016)

The discovery of small-molecule inhibitors of ERK5 for the treatment of cancer
by: Molyneux, Lauren
Published: (2014)

Evaluation of proteomic and transcriptomic biomarker discovery technologies in ovarian cancer
by: Coveney, C. R. E.
Published: (2016)

Early-stage drug discovery of HIV-1 frameshifting modulators
by: Fernandes, Abigail Brenda
Published: (2015)

Assessment of immunological responses to tumour antigens relevant to the development of therapeutic cancer vaccines
by: Rane, S.
Published: (2015)

Developing novel therapeutic strategies for targeting the p53 pathway in renal cell carcinoma
by: Ahmed-Ebbiary, Amro
Published: (2014)

Antibody targeted nanoparticles for imaging and therapy of cancer
by: Vigor, K. L.
Published: (2010)

Discovery of novel variants underlying inherited bleeding and platelet disorders by next generation sequencing
by: Bariana, Tadbir Kaur
Published: (2018)

Antibody targeted magnetic nanoparticle hyperthermia for cancer therapy
by: Kozissnik, B.
Published: (2013)

Nidogens are therapeutic targets for the prevention of tetanus
by: Bercsenyi, K.
Published: (2015)

Targeting therapeutic T cells to tumour niches
by: Carpenter, B. J. M.
Published: (2014)

A study in phthisis, etiological and therapeutic
by: Philip, R. W.
Published: (1887)

LDHA as a potential therapeutic target for medulloblastoma
by: Valvona, Cara Joanna
Published: (2016)

Novel therapeutic targets in NSCLC resistance to Erlotinib
by: Chater, Emily
Published: (2017)

Some organic arsenic compounds of possible therapeutic activity
by: Kennedy, J.
Published: (1933)

Novel therapeutic and diagnostic ultrasound techniques in cancer management
by: Abel, Mark Joshua
Published: (2016)

Cathepsin S as a potential therapeutic target in radioresistant glioblastoma
by: Foster, Robyn
Published: (2017)

The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome
by: Cox, S. T.
Published: (2011)

Mono and dinuclear ruthenium complexes as anti-cancer therapeutic leads
by: Jarman, Paul J.
Published: (2015)

Post-translational modifications of c-FLIP : opportunities for therapeutic intervention
by: Riley, J. S.
Published: (2014)

Identifying genetic dependencies and potential novel therapeutic targets for osteosarcoma
by: Holme, Harriet Katie
Published: (2017)

Mining dopaminergic pathways for novel therapeutic approaches to non-hodgkin's lymphoma
by: Wasik, Agata Magdalena
Published: (2009)

Vectors for therapeutic antisense sequences delivery and the modification of messenger RNA processing
by: Tordo, J.
Published: (2013)

Optimising Reovirus Type 3 Dearing (Reolysin®) as an anti-cancer therapeutic
by: Bolton, Gemma C.
Published: (2016)

HOX/PBX interaction as a therapeutic target in acute myeloid leukaemia
by: Alharbi, Raed A.
Published: (2015)

Clinical and molecular characterisation of prognostic markers and therapeutic targets in prostate cancer
by: Ong, Chee Wee
Published: (2016)

APRIL based therapeutic strategies to target BCMA and TACI in multiple myeloma
by: Lee, L. S. H.
Published: (2017)

mTOR inhibition as a therapeutic strategy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
by: Davies, David Mark
Published: (2011)

The tumour microenvironment and response to therapeutic agents in head and neck squamous carcinoma cells
by: Zimmermann, Miriam
Published: (2011)

Human papillomavirus-mediated response of head and neck cancer cells to therapeutic agents
by: Ayaz, Bushra
Published: (2016)

Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma
by: Mather, Rebecca Louise
Published: (2016)

Clinical biology of OPCML and its potential therapeutic applications in ovarian and breast cancers
by: Louis, Louay
Published: (2014)